Author： Perrone F.
Publisher： Elsevier
ISSN： 1470-2045
Source： Lancet Oncology, Vol.4, Iss.12, 2003-12, pp. : 775-775
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The impact of clinical practice guidelines and clinical trials on treatment decisions
By Darling G.
Surgical Oncology, Vol. 11, Iss. 4, 2002-12 ,pp. :
Access to resources
Recommend
Randomised Consent Designs in Cancer Clinical Trials
By Altman D.G. Whitehead J. Parmar M.K.B. Stenning S.P. Fayers P.M. Machin D.
European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. :
Molecular and clinical risk markers in colon cancer trials
By Hill M.J.
European Journal of Cancer, Vol. 36, Iss. 10, 2000-06 ,pp. :
Clinicians' Attitudes to Clinical Trials of Cancer Therapy
By Fallowfield L. Ratcliffe D. Souhami R.
European Journal of Cancer, Vol. 33, Iss. 13, 1997-11 ,pp. :